Skye Bioscience, Inc. (SKYE)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

6

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Mar-24 6:42 PM View:	29-Feb-24 Grant 0	Arsenault Kaitlyn Melanie Chief Financial Officer		Skye Bioscience, Inc. - SKYE	13% 185.74K to 210.74K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 6:24 PM View:	29-Feb-24 Grant 0	Dhillon Punit Chief Executive Officer Director		Skye Bioscience, Inc. - SKYE	34% 297.01K to 397.01K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:53 PM View:	29-Feb-24 Grant 0	Grayson Paul A. Director		Skye Bioscience, Inc. - SKYE	41% 246.25K to 346.25K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:15 PM View:	13-Mar-24 Purchase $4.50M	5am Partners Vii, LLC 10% Owner		Skye Bioscience, Inc. - SKYE	125% 4.52M to 10.18M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:19 AM View:	29-Feb-24 Grant 0	Diep Tuan Tu Chief Development Officer		Skye Bioscience, Inc. - SKYE	33% 76.83K to 101.83K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 10:00 PM View:	13-Mar-24 Grant $4.50M	Schwab Andrew J. Director 10% Owner		Skye Bioscience, Inc. - SKYE	125% 4.52M to 10.18M	0	0	--	--	Show Txns Hide Txns